A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients.

导出 LinkOut

翻译打印收藏纠错

作者： Marie,Porte ^[1] ; Adrien,Vaudron ^[2] ; Perrine,Crequit ^[3] ; Loig,Vaugier ^[4] ; Thierry,Chatellier ^[5] ; Clémentine,Fronteau ^[6] ; Judith,Raimbourg ^[7] ; Thomas,Goronflot ^[2] ; Jaafar,Bennouna ^[3] ; Elvire,Pons-Tostivint ^[8]

作者单位： Department of Medical Oncology, Centre Hospitalier Universitaire Nantes, Nantes University, Nantes, France. ^[1] Nantes Université, CHU Nantes, Pôle Hospitalo-Universitaire 11: Santé Publique, Clinique des données, INSERM, Nantes, France. ^[2] Department of Medical Oncology, Hospital Foch, Suresnes, France. ^[3] Department of Radiotherapy, Comprehensive Cancer Center, Institut de Cancérologie de l'Ouest, Saint-Herblain, France. ^[4] Medical Oncology Unit, Clinique Mutualiste de l'Estuaire, Saint-Nazaire, France. ^[5] Clinical Pharmacy Unit, Nantes University Hospital, Nantes, France. ^[6] Department of Medical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de l'Ouest, Saint-Herblain, France; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France. ^[7] Department of Medical Oncology, Centre Hospitalier Universitaire Nantes, Nantes University, Nantes, France; Nantes Université, Inserm UMR 1307, CNRS UMR 6075, Université d'Angers, CRCI2NA, Nantes, France. Electronic address: elvire.pons@chu-nantes.fr. ^[8]

关键词 Brain metastases Extensive stage small-cell lung cancer Immune checkpoint inhibitors Platinum-doublet chemotherapy Real-world study

主题词人类(Humans);肺肿瘤(Lung Neoplasms);小细胞肺癌(Small Cell Lung Carcinoma);脑(Brain);脑肿瘤(Brain Neoplasms);免疫疗法(Immunotherapy)

DOI 10.1016/j.cllc.2023.11.009

PMID 38072729

发布时间 2024-04-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交